Hepatic ischemia-reperfusion injury

American Journal of Surgery

Volumn 181, Issue 2, 2001, Pages 160-166

  Serracino Inglott, Ferdinand ^a   Habib, Nagy A ^a   Mathie, Robert T ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Cytokines; Hepatic resection; Hepatic transplantation; Ischemic preconditioning; Kupffer cells; Liver; Neutrophils; Nitric oxide; Nuclear factor B; Reperfusion injury

Indexed keywords

CELL ADHESION MOLECULE; CYTOKINE; ENDOTHELIN; FREE RADICAL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NITRIC OXIDE; OXYGEN;

ANTIOXIDANT ACTIVITY; CELL DAMAGE; CYTOKINE RELEASE; ENTEROHEPATIC CIRCULATION; HEART INFARCTION PREVENTION; HUMAN; INFLAMMATION; KUPFFER CELL; LEUKOCYTE ACTIVATION; LIVER ISCHEMIA; LIVER RESECTION; LIVER TRANSPLANTATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; TREATMENT OUTCOME;

EID: 0035043582     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(00)00573-0     Document Type: Article

References (86)

1. Technique of hepatic vascular exclusion for extensive liver resection
2. Vascular occlusion for liver resections. Operative management and tolerance to ischemia: 142 Cases
3. Liver transplantation and rejection: An overview
4. Hepatic microcirculatory perfusion failure is a determinant for liver dysfunction in warm ischemia-reperfusion
5. Endothelin-1 is involved in hepatic sinusoidal vasoconstriction after ischemia and reperfusion
6. Neutrophils contribute to ischemia/reperfusion injury in rat liver in vivo
7. L-selectin and ICAM-1 mediate reperfusion injury and neutrophil adhesion in the warm ischemic mouse liver
8. Role of platelets in hepatic allograft preservation injury in the rat
9. Leukocyte stasis in hepatic sinusoids
10. The role of cytokine networks in the local liver injury following hepatic ischemia/reperfusion in the rat
11. Up-regulation of oxygen derived free radicals by interleukin-1 in hepatic ischemia/reperfusion injury
12. Is radical hepatic surgery safe?
13. Effect of total hepatic vascular exclusion during liver resection on hepatic ultrastructure
14. Systemic cytokine response to hepatic resections under total vascular exclusion
15. The outcome of steatotic grafts in liver transplantation
16. Liver injury following normothermic ischemia in steatotic rat liver
17. Kupffer cell activation and endothelial cell damage after storage of rat livers: Effects of reperfusion
18. Preservation of human liver grafts in UW solution. Ultrastructural evidence for endothelial and Kupffer cell activation during cold ischemia and after ischemia-reperfusion
19. Apoptosis after ischemia-reperfusion in human liver allografts
20. Clinical short-term results of radiofrequency ablation in primary and secondary liver tumours
21. The contraction of hepatic stellate (Ito) cells stimulated with vasoactive substances. Possible involvement of endothelin 1 and nitric oxide in the regulation of the sinusoidal tonus
22. Response of plasma and tissue endothelin-1 to liver ischemia and its implication in ischemia-reperfusion injury
23. Regulation of hepatic blood flow during resuscitation from hemorrhagic shock: Role of NO and endothelins
24. Nitric oxide in ischaemia-reperfusion injury
25. Role of exogenous L-arginine in hepatic ischemia-reperfusion injury
26. Hepatic ischemia/reperfusion in rats induces iNOS gene transcription by activation of NF-κB
27. Inhibition of nitric oxide synthesis in ischemia/reperfusion of the rat liver is followed by impairment of hepatic microvascular blood flow
28. Involvement of endothelin/nitric oxide balance in hepatic ischemia/reperfusion injury
29. The biological characteristics of cytokines and their implication in surgical injury
30. Role of tumour necrosis factor in disease states and inflammation
31. Cytokine-induced gene expression of a neutrophil chemotactic factor/IL-8 in human hepatocytes
32. Cytokine-mediated activation of vascular endothelium: Physiology and pathology
33. Tumour necrosis factor-induced, superoxide-mediated neutrophil accumulation in cold ischemia/reperfusion in rat liver
34. Interleukin 1 receptor blockade reduces tumour necrosis factor production, tissue injury, and mortality after hepatic ischemia-reperfusion in the rat
35. Interleukin 1 and tumor necrosis factor production as the initial stimulants of liver ischemia and reperfusion injury
36. Pathogenic role of Kupffer cell activation in the reperfusion injury of cold-preserved liver
37. Background and prognostic implications of perireperfusion tissue injuries in human liver transplants: A panel histochemical study
38. Tumor necrosis factor-α in liver transplantation and resection. No evidence for a key role in ischemia-reperfusion injury
39. Interleukin-10 suppresses hepatic/ischemia reperfusion injury in mice: Implications of a central role for nuclear factor κB
40. Involvement of platelet activating factor in microcirculatory disturbances after global hepatic ischemia
41. Platelet-activating factor antagonism enhances the liver's recovery from warm ischemia in situ
42. Inflammation and platelet-activating factor production during hepatic ischemia/reperfusion
43. Involvement of platelet-activating factor in cytokine production and neutrophil activation after hepatic ischemia-reperfusion
44. Protecting the viability of hepatic allografts procured from non-heart-beating donors by blockade of endothelin and platelet activating factor in porcine liver transplantation
45. Modulation of ischemia-reperfusion-induced hepatic injury by Kupffer cells
46. Superoxide generation by neutrophils and Kupffer cells during in vivo reperfusion after hepatic ischemia in rats
47. Kupffer cell exacerbation of hepatocyte hypoxia/reoxygenation injury
48. Neutrophil and Kupffer cell-induced oxidant stress and ischemia-reperfusion injury in rat liver
49. Discriminant quantitation of posttransplant hepatic reticuloendothelial function. The impact of ischemic preservation
50. The effect of neutrophil elastase inhibitor in hepatectomy with ischemia in dogs
51. Neutrophil CD 18-dependent arrest on intercellular adhesion molecule 1 (ICAM-1) in shear flow can be activated through L-selectin
52. A human intercellular adhesion molecule (ICAM-1) distinct from LFA-1
53. Intercellular adhesion molecule 1 (ICAM-1) expression and its role in neutrophil-induced ischaemia reperfusion injury in rat liver
54. Protective effect of monoclonal antibodies to adhesion molecules on rat liver ischemia-reperfusion injury
55. Efficacy of intraportal injection of anti-ICAM-1 monoclonal antibody against liver cell injury following warm ischemia in the rat
56. Leukocytes contribute to hepatic ischemia/reperfusion injury via intercellular adhesion molecule-1-mediated venular adherence
57. 2 fragment of an anti-ICAM-1 monoclonal antibody attenuates liver injury after orthotopic liver transplantation
58. The effects of N-acetylcysteine and anti-intecellular adhesion molecule-1 monoclonal antibody against ischemia-reperfusion injury of the rat steatotic liver produced by a choline-methionine-deficient diet
59. Expression of cytokine-dependent adhesion molecules in postreperfusion biopsy specimens of liver allografts
60. The physiological activity of adenine compounds with special reference to their action upon the mammalian heart
61. The pathophysiology of ischaemic preconditioning
62. Endogenous adenosine inhibits platelet aggregation during myocardial ischemia in dogs
63. Regulatory effects of adenosine and adenine nucleotides on oxygen radical responses of neutrophils
64. Nitric oxide mediates the blood flow response to intravenous adenosine in the rabbit
65. Formation and release of purine catabolites during hypoperfusion, anoxia and ischemia
66. Changes in creatine phosphate, inorganic phosphate and the purine pattern in dog hearts with time of coronary artery occlusion and effect thereon of mioflazine, a nucleoside transport inhibitor
67. Effects of endogenous adenosine augmentation on ischemia and reperfusion injury to the liver
68. Important components of the UW solution
69. Preconditioning with ischemia: A delay in lethal cell injury in ischaemic myocardium
70. Protective effect of ischemic preconditioning on liver preservation-reperfusion injury in rats
71. Prolonged continuous or intermittent vascular inflow occlusion during hemihepatectomy in pigs
72. 2 receptors
73. Protective effect of preconditioning on the injury associated to hepatic ischemia-reperfusion in the rat: Role of nitric oxide and adenosine
74. Increased nitric oxide production in the liver in the perioperative period of partial hepatectomy with Pringle's maneuver
75. Oxidative damage in human liver transplantation
76. Normothermic liver ischemia and antioxidant treatment during hepatic resections
77. Role of free radicals in ischemic rat liver cell injury: Prevention of damage by alpha-tocopherol administration
78. Changes in the levels of endogenous coenzyme Q homologs, alpha-tocopherol, and glutathione in rat liver after hepatic ischemia and reperfusion, and the effect of pretreatment with coenzyme Q10
79. Preventive effects of superoxide dismutase derivatives modified with monosaccharides on reperfusion injury in rat liver transplantation
80. Allopurinol effects in rat liver transplantation on recovery of energy metabolism and free radical-induced damage
81. Impact of N-acetylcysteine on the hepatic microcirculation after orthotopic liver transplantation
82. Effects of warm Carolina rinse and University of Wisconsin solutions on microcirculation, leukocyte adhesion, Kupffer cell activity, and biliary excretion after liver transplantation
83. NF-κB and Rel proteins: Evolutionary conserved mediators of immune responses
84. Oxygen-derived free radicals in postischemic tissue injury
85. Nuclear factor-κB is activated by hyperoxia but does not protect from cell death
86. Ischemia-reperfusion activates the nuclear transcription factor NF-κB and upregulates messenger RNA synthesis of adhesion molecules in the liver in vivo